Z3A-27565-42297
4 vaccinations
3 coded responses
21 check-ins
3 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 66+
- ZIP prefix
- 782 / TX
- Registered
- 2021-02-23
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-02-22
Dose 1 — Pfizer-BioNTech
-
2021-02-23
Registered in v-safe
-
2021-02-23
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Muscle or body achesAdult check-in
- 2021-02-24
- 2021-02-25
-
2021-02-26
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Joint pains, Muscle or body achesAdult check-in
- 2021-02-27
-
2021-02-28
Health check-in — days 1–6 daily, dose 1Feeling: Good · Joint pains, Muscle or body achesAdult check-in
-
2021-03-03
Survey response — day 7, dose 1MedDRA: Arthralgia, Arthritis, Pre-existing disease — Feeling: Good · Site: Pain · Joint pains, Muscle or body achesFree text: The joint pains are probably due to arthritis. I do have noticeable pain in my shoulder above the injection site.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-11
Survey response — day 14, dose 1MedDRA: Vision blurred — Feeling: Good · Be unable to do your normal daily activitiesFree text: Very blurred vision. I started an increased dosage of Gabapentin. That could be the cause.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-15
Dose 2 — Pfizer-BioNTech
-
2021-03-22
Survey response — day 7, dose 2MedDRA: Arthralgia, Diplopia, Office visit, Vision blurred — Feeling: Good · Joint pains · Get care from a doctor or other healthcare professionalFree text: Systemic reaction (other): I have joint pain from arthritis I have had a change in my vision - blurred and double vision. The vision issue is interfering with my daily activities. Just wanted to let you know. · Healthcare visit (other): Doctot's exam in his office. (vision)MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-22
Report sent to call center — day 7, dose 2Get care from a doctor or other healthcare professional1 call case(s)
- 2021-03-29
- 2021-04-05
- 2021-04-12
- 2021-04-19
- 2021-04-26
- 2021-06-14
- 2021-09-17
-
2021-10-04
Dose 3 — Pfizer-BioNTech
- 2021-12-29
-
2022-03-09
Dose 4 — Pfizer-BioNTech
- 2022-03-18
- 2022-04-26
- 2022-06-10
- 2022-09-14
- 2023-03-09
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-02-22 | Pfizer-BioNTech | |
| 2 | 2021-03-15 | Pfizer-BioNTech | |
| 3 | 2021-10-04 | Pfizer-BioNTech | No |
| 4 | 2022-03-09 | Pfizer-BioNTech | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-03-22 | Unsuccessful |
Free text
Release 5 — day 7, dose 1
Systemic reaction (other): The joint pains are probably due to arthritis. I do have noticeable pain in my shoulder above the injection site.
Release 5 — day 14, dose 1
Symptoms: Very blurred vision. I started an increased dosage of Gabapentin. That could be the cause.
Release 6 — day 7, dose 2
Systemic reaction (other): I have joint pain from arthritis I have had a change in my vision - blurred and double vision. The vision issue is interfering with my daily activities. Just wanted to let you know.
Healthcare visit (other): Doctot's exam in his office. (vision)
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Office visit | ✓ | ✓ | ✓ |
| SD | Vision blurred | ✓ | ✓ | ✓ |
| SRO | Arthralgia | ✓ | ✓ | ✓ |
| SRO | Arthritis | ✓ | ✓ | ✓ |
| SRO | Diplopia | ✓ | ✓ | ✓ |
| SRO | Pre-existing disease | ✓ | ✓ | ✓ |
| SRO | Vision blurred | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release